Jean-Francois Gautier
Overview
Explore the profile of Jean-Francois Gautier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
3402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trecan T, Manchon P, Paradis V, et al.
Diabetes Care
. 2023 Apr;
46(7):1354-1362.
PMID: 37043830
Objective: Most people with type 2 diabetes (T2DM) and nonalcoholic steatohepatitis (NASH) or advanced fibrosis (AF) remain undiagnosed, resulting in missed opportunities for early intervention. This multicenter, prospective study assessed...
12.
Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, et al.
iScience
. 2023 Feb;
26(3):106124.
PMID: 36776936
Although tocilizumab treatment in severe and critical coronavirus disease 2019 (COVID-19) patients has proven its efficacy at the clinical level, there is little evidence supporting the effect of short-term use...
13.
Diedisheim M, Pecquet C, Julla J, Carlier A, Potier L, Hartemann A, et al.
Diabetes Technol Ther
. 2023 Feb;
25(4):279-286.
PMID: 36763338
The use of continuous glucose monitoring (CGM) systems and continuous subcutaneous insulin infusion (CSII) devices adhering to the skin can lead to skin reactions. The objective was to determine the...
14.
Mathieu C, Soderberg J, Del Prato S, Felton A, Cos X, de Beaufort C, et al.
Diabetologia
. 2022 Nov;
66(2):247-252.
PMID: 36394645
No abstract available.
15.
Tramunt B, Disse E, Chevalier N, Bordier L, Cazals L, Dupuy O, et al.
Diabetes Ther
. 2022 Nov;
13(11-12):1947-1963.
PMID: 36331712
Introduction: Combining basal insulin (BI) with glucagon-like peptide-1 receptor agonist (GLP-1RA) is recognized as a relevant option to optimize glucose control in type 2 diabetes (T2D). The EASY real-world study...
16.
Sanchez M, Kannengiesser C, Hoang S, Potier L, Fumeron F, Venteclef N, et al.
Cardiovasc Diabetol
. 2022 Oct;
21(1):206.
PMID: 36221106
Background: Type 1 diabetes is associated with accelerated vascular aging and advanced atherosclerosis resulting in increased rates of cardiovascular disease and premature death. We evaluated associations between Leukocyte telomere length...
17.
Mosbah H, Vantyghem M, Nobecourt E, Andreelli F, Archambeaud F, Bismuth E, et al.
Diabetes Obes Metab
. 2022 Apr;
24(8):1565-1577.
PMID: 35445532
Aim: To describe baseline characteristics and follow-up data in patients with lipodystrophy syndromes treated with metreleptin in a national reference network, in a real-life setting. Patients And Methods: Clinical and...
18.
Deckmyn O, Poynard T, Bedossa P, Paradis V, Peta V, Pais R, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327501
In patients with non-alcoholic fatty liver disease (NAFLD) with or without type 2 diabetes mellitus (T2DM), alpha-2 macroglobulin (A2M), apolipoprotein A1 (ApoA1), and haptoglobin are associated with the risk of...
19.
Dillinger J, Patin C, Bonnin P, Vidal-Trecan T, Paven E, Gautier J, et al.
Am J Hypertens
. 2021 Dec;
35(5):414-422.
PMID: 34969077
Background: Heart failure (HF) is frequent in patients with diabetes mellitus (DM), and early detection improves prognosis. We investigated whether analysis of brachial blood pressure (BP) in daily practice can...
20.
Mohammedi K, Abouleka Y, Carpentier C, Potier L, Dubois S, Foussard N, et al.
Diabetes Care
. 2021 Dec;
45(2):407-415.
PMID: 34853028
Objective: The ACE insertion/deletion (I/D) polymorphism has been widely studied in people with diabetes, albeit not with regard to lower-limb amputation (LLA). We examined associations among this polymorphism, plasma ACE...